No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors
byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Updated on: January 29,2024
10

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors
byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Updated on:January 29,2024
10
